Otsuka Pharmaceutical To Acquire Avanir Pharmaceuticals
TOKYO–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc.(AVNR) (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer. The contract was signed on December 2, Japan time. Avanir Pharmaceuticals Avanir is a biopharmaceutical company specializing in CNS diseases….